Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471

News
2021
2020
Archive

June 10, 2021

Vor to Develop Multi-Targeted CAR-Ts with Abound Bio
June 9, 2021

Neurogastrx Announces Agreement with Daewoong Pharmaceutical to Develop Fexuprazan for Treatment of Acid-Related GI Disorders in the U.S.
June 2, 2021

Impel Neuropharma to Present Pivotal, Phase 3 Data From STOP-301 Study at The 63rd Annual Meeting of the American Headache Society
June 2, 2021

Cidara to Present at Mycology 2021 Conference
June 1, 2021

Precision NanoSystems joins Danaher’s Life Sciences Platform
May 28, 2021

Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research to Broaden its Portfolio of Small Molecule Medicines
May 26, 2021

Novome Biotechnologies Appoints Dr. David N. Cook and Zachary Hornby to its Board of Directors
May 21, 2021

CinCor Pharma Announces Appointments of Three Experienced Independent Members to Its Board of Directors
May 20, 2021

Amber Guild joins TMRW Life Sciences’ distinguished C-Suite as CMO
May 20, 2021

Artiva Biotherapeutics Appoints Two New Independent Members to Its Board of Directors

© 2021 5AM Venture Management LLC